Listened yesterday to a ML health tech analyst and a call in question came regarding BV. He discussed the past 4 leaders, the expansion errors and successes. The 100 million gift given by walking away from a purchase was explained, and finally the buy/sell strategy. He said all the easy money has been made ( those who purchased at the .80 per share low. ). He stated the company will drop again in value and WHEN it drops below $2.00 per share, he will consider changing his opinion. He still feels that BV shouldn’t be a part of one’s portfolio.